ClinConnect ClinConnect Logo
Search / Trial NCT06079918

Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania

Launched by GEORGE WASHINGTON UNIVERSITY · Oct 6, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

Pregnancy Multiple Micronutrient Supplementation Iron Anemia Tanzania

ClinConnect Summary

This clinical trial is looking at the effects of different types of multiple micronutrient supplements (MMS) on preventing anemia in pregnant women in Tanzania. Anemia is a condition where you don’t have enough healthy red blood cells, which can be more common during pregnancy. The study will compare two types of MMS that contain different amounts of iron to see which one works better for preventing moderate or severe anemia in mothers-to-be.

To join this study, participants need to be pregnant women who are less than 20 weeks along, at least 18 years old, and planning to stay in Dar es Salaam until six weeks after giving birth. They should also be visiting the clinic for their first prenatal check-up. However, women with severe anemia or certain blood disorders, like sickle cell disease, cannot participate. If you join the trial, you will receive either the standard MMS or the new formulation, and the results will help improve care for pregnant women in Tanzania and similar regions.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Attending first ANC visit at study clinics
  • Pregnant women \< 20 weeks gestation by last menstrual period (LMP)
  • Aged ≥ 18 years old
  • Intending to stay in Dar es Salaam until 6 weeks post delivery
  • Provides informed consent
  • Exclusion Criteria:
  • Severe anemia (defined as hemoglobin \< 8.5 g/dL per Tanzania standard of care)
  • Sickle cell disease (SS and SC) and hemoglobin C disease (CC) as tested by HemoTypeSC
  • Concurrently enrolled in another nutritional clinical trial
  • Pregnant women with disability or condition which would impair their ability to provide informed consent and complete study procedures.

About George Washington University

George Washington University (GWU) is a leading academic institution dedicated to advancing medical research and education. As a clinical trial sponsor, GWU leverages its extensive resources and expertise to facilitate innovative studies that aim to improve healthcare outcomes. The university's commitment to ethical research practices, collaboration with multidisciplinary teams, and engagement with diverse populations underscores its role in addressing critical health challenges. By fostering a rigorous scientific environment, GWU strives to translate research findings into effective clinical applications, ultimately enhancing patient care and contributing to the broader medical community.

Locations

Dar Es Salaam, , Tanzania

Patients applied

0 patients applied

Trial Officials

Blair Wylie, MD, MPH

Principal Investigator

Columbia University

Honorati Masanja, PhD

Principal Investigator

Ifakara Health Institute

Alfa Muhihi, MD, MPH

Principal Investigator

Africa Academy for Public Health

Andrea Pembe, MD, MMed, PhD, FCOG

Principal Investigator

Muhimbili University of Health and Allied Sciences

Emily R Smith, ScD, MPH

Principal Investigator

The Goerge Washington University

Christopher R Sudfeld, ScD, ScM

Principal Investigator

Harvard University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported